PSMA-Targeted Radiolabeled Peptide for Imaging and Therapy in Prostate Cancer: Preclinical Evaluation of Biodistribution and Therapeutic Efficacy.

Chen MW, Huang YR, Lo WL, Lee SY, Lo SN, Wang SM, Chang KW.

Open source

DOI
10.3390/ijms26157580
Published
2025-08-05
Container
Int J Mol Sci
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms26157580,
  title = {PSMA-Targeted Radiolabeled Peptide for Imaging and Therapy in Prostate Cancer: Preclinical Evaluation of Biodistribution and Therapeutic Efficacy.},
  author = {Chen MW and  Huang YR and  Lo WL and  Lee SY and  Lo SN and  Wang SM and  Chang KW.},
  year = {2025},
  journal = {Int J Mol Sci},
  doi = {10.3390/ijms26157580},
  url = {https://doi.org/10.3390/ijms26157580}
}

RIS

TY  - JOUR
TI  - PSMA-Targeted Radiolabeled Peptide for Imaging and Therapy in Prostate Cancer: Preclinical Evaluation of Biodistribution and Therapeutic Efficacy.
AU  - Chen MW
AU  -  Huang YR
AU  -  Lo WL
AU  -  Lee SY
AU  -  Lo SN
AU  -  Wang SM
AU  -  Chang KW.
PY  - 2025
JO  - Int J Mol Sci
DO  - 10.3390/ijms26157580
UR  - https://doi.org/10.3390/ijms26157580
ER  - 

APA

MW, C., YR, H., WL, L., SY, L., SN, L., SM, W., & KW., C. (2025). PSMA-Targeted Radiolabeled Peptide for Imaging and Therapy in Prostate Cancer: Preclinical Evaluation of Biodistribution and Therapeutic Efficacy.. Int J Mol Sci. https://doi.org/10.3390/ijms26157580

Source records